MOR202 for Refractory MN

Clinical trial NCT04893096 · COMPLETED

Trial details

NCT number: NCT04893096
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Membranous Nephropathy

Start date: 2021-10-22
Primary completion: 2025-02-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.